GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shenzhen YHLO Biotech Co Ltd (SHSE:688575) » Definitions » Short-Term Debt & Capital Lease Obligation

Shenzhen YHLO Biotech Co (SHSE:688575) Short-Term Debt & Capital Lease Obligation : ¥318 Mil (As of Mar. 2025)


View and export this data going back to 2021. Start your Free Trial

What is Shenzhen YHLO Biotech Co Short-Term Debt & Capital Lease Obligation?

Short-Term Debt & Capital Lease Obligation is the portion of a company's debt and capital lease obligation that need to be paid within the next 12 months. It equals Short-Term Debt plus Short-Term Capital Lease Obligation. This gives investors an idea of how much money the company needs to pay down for the principle of its debt. Shenzhen YHLO Biotech Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2025 was ¥318 Mil.

Long-Term Debt & Capital Lease Obligation is the debt and capital lease obligation due more than 12 months in the future. Shenzhen YHLO Biotech Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2025 was ¥597 Mil.


Shenzhen YHLO Biotech Co Short-Term Debt & Capital Lease Obligation Historical Data

The historical data trend for Shenzhen YHLO Biotech Co's Short-Term Debt & Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhen YHLO Biotech Co Short-Term Debt & Capital Lease Obligation Chart

Shenzhen YHLO Biotech Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Short-Term Debt & Capital Lease Obligation
Get a 7-Day Free Trial 306.82 155.55 284.41 172.14 317.96

Shenzhen YHLO Biotech Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Short-Term Debt & Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 161.68 252.00 305.65 317.96 317.61

Shenzhen YHLO Biotech Co Short-Term Debt & Capital Lease Obligation Calculation

This is the portion of a company's debt and capital lease obligation that need to be paid within the next 12 months. It equals Short-Term Debt plus Short-Term Capital Lease Obligation. This gives investors an idea of how much money the company needs to pay down for the principle of its debt.

In the notes to balance sheet in annual (10-K) or quarterly (10-Q) reports, companies usually break down the details of the debt, their due dates, the interest rates etc.


Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term


Shenzhen YHLO Biotech Co Short-Term Debt & Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Shenzhen YHLO Biotech Co's Short-Term Debt & Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


Shenzhen YHLO Biotech Co Business Description

Traded in Other Exchanges
N/A
Address
Baolong 2nd Road, Baolong Street, Building 1, Yahuilong Biological Technology Factory, Longgang District, Guangdong, Shenzhen, CHN, 518116
Shenzhen YHLO Biotech Co Ltd is an innovative enterprise focusing on overall clinical laboratory solutions with leading domestic technology and integrated research, production and marketing. Its main business is research and development, production and sales of in vitro diagnostic instruments and supporting reagents based on chemiluminescence immunoassay.
Executives
Song Yong Bo Directors, senior managers
Xiao Yu Jin senior management
Liao Li Sheng Directors, senior managers
Pang Shi Hong senior management
Hu Kun Hui Director
Xia Fu Zhen Core technical personnel

Shenzhen YHLO Biotech Co Headlines

No Headlines